- Home
- DYN vs GTX Comparison
DYN vs GTX Comparison
Compare DYN & GTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYN | GTX |
|---|---|---|
| Founded | 1984 | 2018 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.5B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | DYN | GTX |
|---|---|---|
| Price | $18.21 | $29.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 5 |
| Target Price | ★ $37.00 | $20.40 |
| AVG Volume (30 Days) | 1.7M | ★ 2.5M |
| Earning Date | 05-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | N/A | ★ 20.63 |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $3,584,000,000.00 |
| Revenue This Year | N/A | $4.16 |
| Revenue Next Year | N/A | $3.27 |
| P/E Ratio | ★ N/A | $59.52 |
| Revenue Growth | N/A | ★ 3.14 |
| 52 Week Low | $8.25 | $9.58 |
| 52 Week High | $25.00 | $29.17 |
Technical Indicators
Market Signals| Indicator | DYN | GTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.79 | 85.07 |
| Support Level | $16.47 | $17.30 |
| Resistance Level | $19.65 | N/A |
| Average True Range (ATR) | 0.98 | 1.13 |
| MACD | -0.10 | 0.74 |
| Stochastic Oscillator | 39.93 | 97.24 |
Price Performance
Historical ComparisonAbout DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.